Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0107-2018

Drug recall · December 13, 2017

Isradapine Capsules USP 2.5 mg recall

Why: Failed Impurities/Degradation Specifications

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013

Lots / codes

Lot #: P0910-017, Exp. 05/2019

Quantity
1264 bottles
Company
Elite Laboratories Inc., Northvale, NJ
Distribution
NY only
Initiated
November 13, 2017 · Voluntary: Firm initiated
Classified
December 5, 2017
Reported
December 13, 2017
Ended
March 15, 2019
How notified
E-Mail

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.